Accolade, Inc. ACCD NASDAQ

NASDAQ Global Select • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score

40/100

1/7 Pass

SharesGrow Intrinsic Value

Income Statement Balance Sheet Cash Flow Statement

Annual Quarterly

Accolade, Inc. (ACCD) reported total assets of $788.15M and total liabilities of $342.69M for fiscal year 2024, resulting in total equity of $445.47M.

The company held $237.03M in cash and short-term investments. Total debt stood at $241.65M, with net debt of $55.93M. The Debt-to-Equity (D/E) ratio was 0.54 (moderate).

Current ratio is 2.64, indicating strong short-term liquidity.

Criteria supported by this page:

HEALTH (75/100, Pass) — Debt-to-Equity of 0.54, current ratio of 2.64 — balance sheet is strong
MOAT (53/100) — Total assets $788.15M and equity $445.47M support the company's competitive scale
VALUE (50/100) — Debt-to-Equity 0.54 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 40/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score

40/100

SG Score

View full scorecard →

VALUE

50/100

Price-to-Earnings & upside

→ Valuation

✗

FUTURE

34/100

Analyst consensus

→ Forecast

✗

PAST

0/100

→ Income

✓

HEALTH

75/100

Debt-to-Equity & liquidity

Proven by this page

MOAT

53/100

→ Income

GROWTH

58/100

→ Income

✗

INCOME

10/100

→ Income

Accolade, Inc. Balance Sheet History

Metric	FY2024	FY2023	FY2022	FY2021
Total Assets	$788.15M	$903.07M	$1.29B	$475.51M
Total Liabilities	$342.69M	$429.28M	$429.74M	$84.66M
Total Debt	$241.65M	$316.8M	$319.74M	$0.00
Cash & Investments	$237.03M	$321.08M	$365.85M	$433.88M
Total Stockholders Equity	$445.47M	$473.79M	$855.79M	$390.85M